Skip to main content

Unpacking Banxico’s minutes, Sinovac success?

The fairly hawkish minutes to Banxico's last meeting, where it delivered a surprise 25bp hike, reaffirm our initial view that more tightening is in the pipeline. We now expect a further 125bp of hikes, to 5.50%, by Q1 2022 (previously 5.25%). Otherwise, new virus cases are now falling sharply in Chile and Uruguay which may be encouraging evidence that their rapid vaccine rollouts, which primarily use the Sinovac jab, are helping to quash infections.

Become a client to read more

This is premium content that requires an active Capital Economics subscription to view.

Already have an account?

You may already have access to this premium content as part of a paid subscription.

Sign in to read the content in full or get details of how you can access it

Register for free

Sign up for a free account to gain:

  • Unlock additional content
  • Register for Capital Economics events
  • Receive email updates and economist-curated newsletters
  • Request a free trial of our services


Get access